Session Details

[JS15★☆]Pioneering Cancer Therapies Through Pharmaceutical Science (the 3rd time) —Toward Generating New Insights—

Sun. Mar 29, 2026 1:10 PM - 3:10 PM JST
Sun. Mar 29, 2026 4:10 AM - 6:10 AM UTC
Room 04 (E301)
Organizer: Ryuji Ikeda (Univ. Miyazaki Hosp. Dept. Pharm), Tomohiro Miyake (Dept. Pharm., Ise Red Cross Hosp.), Motohiko Sano (Hoshi Univ.), Yukiyoshi Fujita (Div. Pharm., Gunma Prefectural Cancer Center)
Co-sponsored by:
The Pharmaceutical Society of Japan,
the Japanese Society of Pharmaceutical Health Care and Sciences

オーガナイザー挨拶
池田 龍二(宮崎大病院薬)

[JS15-1]Converting clinical questions into research questions: From the clinical“Why?”to the research“How?”

○Yoshitaka Saito1 (1. Faculty of Pharmaceutical Sciences, Hokkaido University of Science)

[JS15-2]Innovating preventive strategies in cancer supportive care via data-driven clinical pharmacology: Synergizing big data analysis and basic research

○Mitsuhiro Goda1,2, Keisuke Ishizawa2,3,4 (1. Grad. Sch. Biomed. & Health Sci. Hiroshima Univ., 2. Grad. Sch. Biomed. Sci. Tokushima Univ., 3. Dept. Pharm., Tokushima Univ. Hosp., 4. Clin. Res. Ctr., Tokushima Univ. Hosp.)

[JS15-3]Implementing high-quality clinical research: The impact of evidence generation

○Toshinobu Hayashi1 (1. Fac. Pharm. Sci., Fukuoka Univ.)

[JS15-4]Bridging generated evidence to clinical practice — How to interpret and apply guidelines

○Takeshi Aoyama1 (1. Department of Pharmacy Cancer Institute Hospital Japanese Foundation for Cancer Research)

オーガナイザー総括
三宅 知宏(伊勢赤十字病院薬)